Work

Abstract PS5-05-16: From Keynote522 to real world evidence: The use of Pembrolizumab in early triple-negative breast cancer

Year: 2026

Type: conference-abstract

Source: Clinical Cancer Research

DOI: 10.1158/1557-3265.sabcs25-ps5-05-16

Authors: J. Roth, J. Albers, M. Gerken, O. Ortmann, S. Seitz

Institution: University of Regensburg

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7129431532

Cites:

Cited by:

Related to: